ACI: Drug and Medical Device Litigation Conference – Agenda Highlights Announced

NEW YORK - July 16, 2013 - PRLog -- New York

The American Conference Institute, organizers of the 18th Annual Drug and Medical Device Litigation Conference taking place December 9 – 11, 2013 at the Marriott Marquis in New York, today announced key highlights from this year’s program agenda.

Participation by Seven Federal and State Judges Involved in Groundbreaking Products Liability Cases

Attendees at this year’s conference will have a rare opportunity to hear the perspectives of renowned jurists from the state and federal bench, with an opportunity for attendees to ask questions.  Gain valuable understanding of how members of the bench coordinate and manage state and federal proceedings in pharmaceutical and device mass tort actions.  The judges will offer their insights on MDLs and discuss their judicial pet peeves.  

Enhanced Networking and Business Development Opportunities

This year’s conference will include an exciting speed networking event, enabling attendees to interact with in-house counsel in a smaller group setting.  At the conclusion of the regular conference, a post-conference Business Development Master Class will shed light on how companies select and evaluate their outside counsel.

Making Strategic Litigation Decisions

Program Director Stacey Evans remarked, “This conference is the culmination of many weeks of detailed research with industry leaders at more than 75 law firms, pharmaceutical and device companies.”

Full information on the forum can be found at www.drugandmed.com